hh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prediction of fraction metabolized via CYP3A in humans utilizing cryopreserved human hepatocytes from a set of 12 single donors
KaLy-Cell, Plobsheim, France.
UCB Pharma S.A, Braine-l'Alleud, Belgium.
Halmstad University. (Department of Strategic Support)
Centre de Chirurgie Viscérale et de Transplantation, Hôpital de Hautepierre, Strasbourg, France.
Show others and affiliations
2014 (English)In: Xenobiotica, ISSN 0049-8254, E-ISSN 1366-5928, Vol. 44, no 1, 17-27 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
London, United Kingdom: Informa Healthcare, 2014. Vol. 44, no 1, 17-27 p.
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:hh:diva-27126DOI: 10.3109/00498254.2013.809617ISI: 000328261300003PubMedID: 23883428Scopus ID: 2-s2.0-84890512792OAI: oai:DiVA.org:hh-27126DiVA: diva2:766293
Available from: 2014-11-26 Created: 2014-11-26 Last updated: 2017-03-16Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Lutz, Mareike
By organisation
Halmstad University
In the same journal
Xenobiotica
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 48 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf